Question · asked by 1 review

Lamotrigine vs placebo: 50% or greater reduction in seizure frequency

Population
people with drug‐resistant focal epilepsy
Intervention
Lamotrigine
Comparison
placebo
Outcome
50% or greater reduction in seizure frequency

Summary of findings: lamotrigine probably leads to higher 50% or greater reduction in seizure frequency (ITT analysis) compared with placebo (moderate certainty).

What each review found

Current versions only
FindingEffectStudiesGRADE certainty
Summary of findings: lamotrigine vs placebo
50% or greater reduction in seizure frequency (ITT analysis) · participants with drug‐resistant focal epilepsy
Summary of findings: lamotrigine probably leads to higher 50% or greater reduction in seizure frequency (ITT analysis) compared with placebo (moderate certainty).
Lamotrigine add‐on therapy for drug‐resistant focal epilepsy (2023) · Cochrane Headline outcomes only
RR 1.8 [1.45, 2.23]12 studies · 1322 participantsModerate

Findings are shown side by side, never pooled across reviews.

The reviews

ReviewSearched up toIncluded studiesAMSTAR 2
Lamotrigine add‐on therapy for drug‐resistant focal epilepsy
2023 · Cochrane Headline outcomes only
Not reportedNot extractedNot assessed

The same intervention and outcome, asked in another population or against another comparator.

How reviews are matched to this question

Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.